📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

Rhythm Pharmaceuticals Inc (RYTM)

NASDAQ
Currency in USD
Disclaimer
48.09
+0.89(+1.89%)
Closed
After Hours
48.090.00(0.00%)
RYTM Scorecard
Full Analysis
Impressive gross profit margins
Fair Value
Day's Range
47.1148.93
52 wk Range
21.3455.64
Prev. Close
47.2
Open
47.15
Day's Range
47.11-48.93
52 wk Range
21.34-55.64
Volume
277,915
Average Volume (3m)
432,692
1-Year Change
105.25%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
RYTM Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
59.30
Upside
+23.31%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year
Show more

Rhythm Pharma Company Profile

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company’s lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Compare RYTM to Peers and Sector

Metrics to compare
RYTM
Peers
Sector
Relationship
P/E Ratio
−11.3x−2.4x−0.6x
PEG Ratio
0.34−0.060.00
Price/Book
74.7x2.7x2.6x
Price / LTM Sales
28.9x12.8x3.3x
Upside (Analyst Target)
19.7%199.0%44.5%
Fair Value Upside
Unlock17.2%6.0%Unlock

FAQ

What Is the Rhythm Pharma (RYTM) Stock Price Today?

The Rhythm Pharma stock price today is 48.09.

What Stock Exchange Does Rhythm Pharma Trade On?

Rhythm Pharma is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Rhythm Pharma?

The stock symbol for Rhythm Pharma is "RYTM."

What Is the Rhythm Pharma Market Cap?

As of today, Rhythm Pharma market cap is 2.94B.

What is Rhythm Pharma Earnings Per Share?

The Rhythm Pharma EPS is -4.38.

What Is the Next Rhythm Pharma Earnings Date?

Rhythm Pharma will release its next earnings report on 04 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.